Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012 (2012), Article ID 104105, 7 pages
http://dx.doi.org/10.1100/2012/104105
Review Article

The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development

Mood Disorders Research Program, Butler Hospital and Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI 02906, USA

Received 26 January 2012; Accepted 28 February 2012

Academic Editors: A. Czurko, S. M. Dursun, H. Luddens, and P. Stratta

Copyright © 2012 Noah S. Philip et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [25 citations]

The following is the list of published articles that have cited the current article.

  • Elena Mantione, Stefano Micheloni, Constanza Alcaino, Karina New, Simone Mazzaferro, and Isabel Bermudez, “Allosteric modulators of alpha 4 beta 2 nicotinic acetylcholine receptors: a new direction for antidepressant drug discovery,” Future Medicinal Chemistry, vol. 4, no. 17, pp. 2217–2230, 2012. View at Publisher · View at Google Scholar
  • Carmen Frias-Dominguez, Julieta Garduno, Salvador Hernandez, Rene Drucker-Colin, and Stefan Mihailescu, “Flattening plasma corticosterone levels increases the prevalence of serotonergic dorsal raphe neurons inhibitory responses to nicotine in adrenalectomised rats,” Brain Research Bulletin, vol. 98, pp. 10–22, 2013. View at Publisher · View at Google Scholar
  • Jason Smucny, and Jason Tregellas, “Nicotinic modulation of intrinsic brain networks in schizophrenia,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Jonas O. Hannestad, Kelly P. Cosgrove, Nicole F. DellaGioia, Evgenia Perkins, Frederic Bois, Zubin Bhagwagar, John P. Seibyl, Tristan D. McClure-Begley, Marina R. Picciotto, and Irina Esterlis, “Changes in the Cholinergic System between Bipolar Depression and Euthymia as Measured with [123I]5IA Single Photon Emission Computed Tomography,” Biological Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Miriam Melis, Simona Scheggi, Gianfranca Carta, Camilla Madeddu, Salvatore Lecca, Antonio Luchicchi, Francesca Cadeddu, Roberto Frau, Liana Fattore, Paola Fadda, M. Grazia Ennas, M. Paola Castelli, Walter Fratta, Bjorn Schilstrom, Sebastiano Banni, M. Graziella De Montis, and Marco Pistis, “PPAR alpha Regulates Cholinergic-Driven Activity of Midbrain Dopamine Neurons via a Novel Mechanism Involving alpha 7 Nicotinic Acetylcholine Receptors,” Journal Of Neuroscience, vol. 33, no. 14, pp. 6203–+, 2013. View at Publisher · View at Google Scholar
  • Laura L. Hurley, and Yousef Tizabi, “Neuroinflammation, Neurodegeneration, and Depression,” Neurotoxicity Research, vol. 23, no. 2, pp. 131–144, 2013. View at Publisher · View at Google Scholar
  • Elizabeth Ralevski, J. Serrita Jane, Erin O’Brien, Ellen Edens, Bachaar Arnaout, Karin Kerfoot, Kathryn Keegan, Jane Weiner, Melanie Russo, and Ismene Petrakis, “Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence,” Journal of Dual Diagnosis, vol. 9, no. 4, pp. 301–310, 2013. View at Publisher · View at Google Scholar
  • Jamie Winderbaum Fernandez, J. Alex Grizzell, and Lynn Wecker, “The role of estrogen receptor β and nicotinic cholinergic receptors in postpartum depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 40, pp. 199–206, 2013. View at Publisher · View at Google Scholar
  • Olivia F. O’Leary, Timothy G. Dinan, and John F. Cryan, “Faster, better, stronger: Towards new antidepressant therapeutic strategies,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Mark J. Millan, “On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal,” International Journal of Neuropsychopharmacology, vol. 17, no. 7, pp. 1009–1037, 2014. View at Publisher · View at Google Scholar
  • Li-Fang Yu, Han-Kun Zhang, Barbara J. Caldarone, J. Brek Eaton, Ronald J. Lukas, and Alan P. Kozikowski, “Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors,” Journal of Medicinal Chemistry, pp. 140702161208006, 2014. View at Publisher · View at Google Scholar
  • Tue Heesgaard Jepsen, Anders A. Jensen, Mads Henrik Lund, Emil Glibstrup, and Jesper Langgaard Kristensen, “Synthesis and Pharmacological Evaluation of DHβE Analogues as Neuronal Nicotinic Acetylcholine Receptor Antagonists,” ACS Medicinal Chemistry Letters, pp. 140527093431001, 2014. View at Publisher · View at Google Scholar
  • Peter H. Hutson, Frank I. Tarazi, Manisha Madhoo, Craig Slawecki, and Ashwin A. Patkar, “Preclinical Pharmacology of Amphetamine: Implications for the Treatment of Neuropsychiatric Disorders,” Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Peggy L. O'Brien, Cindy Parks Thomas, Dominic Hodgkin, Katharine R. Levit, and Tami L. Mark, “The Diminished Pipeline for Medications to Treat Mental Health and Substance Use Disorders,” Psychiatric Services, vol. 65, no. 12, pp. 1433–1438, 2014. View at Publisher · View at Google Scholar
  • Sawsan Aboul-Fotouh, “Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters,” Psychopharmacology, 2014. View at Publisher · View at Google Scholar
  • Thomas S. A. Heugebaert, Melissa Van Overtveldt, Ann De Blieck, Benjamin Wuyts, Patrick Augustijns, Eugenia Ponce-Gamez, Alicia Rivera, Dominic De Groote, Romain A. Lefebvre, Patrick Wouters, Theo Meert, Jacques Devulder, and Christian V. Stevens, “Synthesis of 1-substituted epibatidine analogues and their in vitro and in vivo evaluation as alpha(4)beta(2) nicotinic acetylcholine receptor ligands,” Rsc Advances, vol. 4, no. 5, pp. 2226–2234, 2014. View at Publisher · View at Google Scholar
  • Shafiqur Rahman, “Targeting brain nicotinic acetylcholine receptors to treat major depression and co-morbid alcohol or nicotine addiction,” CNS and Neurological Disorders - Drug Targets, vol. 14, no. 5, pp. 647–653, 2015. View at Publisher · View at Google Scholar
  • Brian J. Lithgow, Amber L. Garrett, Zahra M. Moussavi, Caroline Gurvich, Jayashri Kulkarni, Jerome J. Maller, and Paul B. Fitzgerald, “Major depression and electrovestibulography,” The World Journal of Biological Psychiatry, pp. 1–17, 2015. View at Publisher · View at Google Scholar
  • Marilia Valli, Andresa Heemann Betti, Amanda Danuello, Marcos Pivatto, Fernanda Centurião, Camila Boque Antonio, Stela Maris Kuze Rates, and Vanderlan da Silva Bolzani, “Pyridinic analog of the natural product (−)-spectaline as potential adjuvant for the treatment of central nervous system disorders,” Bioorganic & Medicinal Chemistry Letters, 2015. View at Publisher · View at Google Scholar
  • Glenn E. Kirsch, Nikolai B. Fedorov, Yuri A. Kuryshev, Zhiqi Liu, Lucas C. Armstrong, and Michael S. Orr, “Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine Receptors,” ASSAY and Drug Development Technologies, vol. 14, no. 6, pp. 333–344, 2016. View at Publisher · View at Google Scholar
  • Jing Han, Dong-sheng Wang, Shui-bing Liu, and Ming-gao Zhao, “Cytisine, a Partial Agonist of α4β2 Nicotinic Acetylcholine Receptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like Behaviors,” Biomolecules & Therapeutics, vol. 24, no. 3, pp. 291–297, 2016. View at Publisher · View at Google Scholar
  • Ansel T. Hillmer, Ming-Qiang Zheng, Songye Li, Matthias Scheunemann, Shu-fei Lin, Daniel Holden, David Labaree, Jim Ropchan, Rodrigo Teodoro, Winnie Deuther-Conrad, Richard E. Carson, Peter Brust, and Yiyun Huang, “PET imaging evaluation of [F-18]DBT-10, a novel radioligand specific to alpha(7) nicotinic acetylcholine receptors, in nonhuman primates,” European Journal Of Nuclear Medicine And Molecular Imaging, vol. 43, no. 3, pp. 537–547, 2016. View at Publisher · View at Google Scholar
  • Anna Zakrzewicz, Katrin Richter, Alisa Agné, Sigrid Wilker, Kathrin Siebers, Bijan Fink, Gabriela Krasteva-Christ, Mike Althaus, Winfried Padberg, Arik J. Hone, J. Michael McIntosh, and Veronika Grau, “Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10,” Frontiers in Cellular Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar
  • Ansel T Hillmer, Jim Ropchan, Rodrigo Teodoro, Winnie Deuther-Conrad, Irina Esterlis, Kelly P Cosgrove, Peter Brust, Richard E Carson, Yiyun Huang, Songye Li, Ming-Qiang Zheng, Matthias Scheunemann, Shu-Fei Lin, Nabeel Nabulsi, Daniel Holden, Richard Pracitto, and David Labaree, “PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans.,” European journal of nuclear medicine and molecular imaging, vol. 44, no. 6, pp. 1042–1050, 2017. View at Publisher · View at Google Scholar
  • Ismene L. Petrakis, Elizabeth Ralevski, Ralitza Gueorguieva, Stephanie S. O'Malley, Albert Arias, Kevin A. Sevarino, Jane S. Jane, Erin O'Brien, and John H. Krystal, “Mecamylamine treatment for alcohol dependence: a randomized controlled trial,” Addiction, 2017. View at Publisher · View at Google Scholar